| UniProt ID | H11_HUMAN | |
|---|---|---|
| UniProt AC | Q02539 | |
| Protein Name | Histone H1.1 | |
| Gene Name | HIST1H1A | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 215 | |
| Subcellular Localization | Nucleus . Chromosome . Mainly localizes in euchromatin. | |
| Protein Description | Histone H1 protein binds to linker DNA between nucleosomes forming the macromolecular structure known as the chromatin fiber. Histones H1 are necessary for the condensation of nucleosome chains into higher-order structured fibers. Acts also as a regulator of individual gene transcription through chromatin remodeling, nucleosome spacing and DNA methylation (By similarity).. | |
| Protein Sequence | MSETVPPAPAASAAPEKPLAGKKAKKPAKAAAASKKKPAGPSVSELIVQAASSSKERGGVSLAALKKALAAAGYDVEKNNSRIKLGIKSLVSKGTLVQTKGTGASGSFKLNKKASSVETKPGASKVATKTKATGASKKLKKATGASKKSVKTPKKAKKPAATRKSSKNPKKPKTVKPKKVAKSPAKAKAVKPKAAKARVTKPKTAKPKKAAPKKK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSETVPPAP ------CCCCCCCCC | 41.81 | 23663014 | |
| 2 | Acetylation | ------MSETVPPAP ------CCCCCCCCC | 41.81 | - | |
| 4 | Phosphorylation | ----MSETVPPAPAA ----CCCCCCCCCCC | 30.88 | 23663014 | |
| 12 | Phosphorylation | VPPAPAASAAPEKPL CCCCCCCCCCCCCCC | 27.37 | 23663014 | |
| 17 | Acetylation | AASAAPEKPLAGKKA CCCCCCCCCCCCCCC | 44.25 | - | |
| 17 | Ubiquitination | AASAAPEKPLAGKKA CCCCCCCCCCCCCCC | 44.25 | 23000965 | |
| 22 | Acetylation | PEKPLAGKKAKKPAK CCCCCCCCCCCHHHH | 43.90 | 17043054 | |
| 22 | Ubiquitination | PEKPLAGKKAKKPAK CCCCCCCCCCCHHHH | 43.90 | 23000965 | |
| 22 | Methylation | PEKPLAGKKAKKPAK CCCCCCCCCCCHHHH | 43.90 | 17043054 | |
| 23 | Ubiquitination | EKPLAGKKAKKPAKA CCCCCCCCCCHHHHH | 65.60 | 23000965 | |
| 23 | Methylation | EKPLAGKKAKKPAKA CCCCCCCCCCHHHHH | 65.60 | 17043054 | |
| 26 | Acetylation | LAGKKAKKPAKAAAA CCCCCCCHHHHHHHH | 55.88 | 20167786 | |
| 36 | Ubiquitination | KAAAASKKKPAGPSV HHHHHHCCCCCCCCH | 62.59 | 29967540 | |
| 37 | Ubiquitination | AAAASKKKPAGPSVS HHHHHCCCCCCCCHH | 43.78 | 29967540 | |
| 37 | Other | AAAASKKKPAGPSVS HHHHHCCCCCCCCHH | 43.78 | - | |
| 42 | Phosphorylation | KKKPAGPSVSELIVQ CCCCCCCCHHHHHHH | 37.04 | 21406692 | |
| 44 | Phosphorylation | KPAGPSVSELIVQAA CCCCCCHHHHHHHHH | 30.90 | 21406692 | |
| 52 | Phosphorylation | ELIVQAASSSKERGG HHHHHHHHCCCCCCC | 37.85 | 21406692 | |
| 53 | Phosphorylation | LIVQAASSSKERGGV HHHHHHHCCCCCCCC | 40.48 | 21406692 | |
| 54 | Phosphorylation | IVQAASSSKERGGVS HHHHHHCCCCCCCCC | 35.72 | 21406692 | |
| 55 | Ubiquitination | VQAASSSKERGGVSL HHHHHCCCCCCCCCH | 54.07 | 29967540 | |
| 55 | Other | VQAASSSKERGGVSL HHHHHCCCCCCCCCH | 54.07 | - | |
| 57 | Citrullination | AASSSKERGGVSLAA HHHCCCCCCCCCHHH | 51.40 | - | |
| 57 | Citrullination | AASSSKERGGVSLAA HHHCCCCCCCCCHHH | 51.40 | - | |
| 61 | Phosphorylation | SKERGGVSLAALKKA CCCCCCCCHHHHHHH | 18.63 | 24719451 | |
| 66 | Malonylation | GVSLAALKKALAAAG CCCHHHHHHHHHHCC | 31.13 | 26320211 | |
| 66 | Ubiquitination | GVSLAALKKALAAAG CCCHHHHHHHHHHCC | 31.13 | 23000965 | |
| 67 | Sumoylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 67 | Ubiquitination | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | 23000965 | |
| 67 | Sumoylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 67 | Other | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 67 | Acetylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | - | |
| 67 | Malonylation | VSLAALKKALAAAGY CCHHHHHHHHHHCCC | 49.86 | 26320211 | |
| 74 | Phosphorylation | KALAAAGYDVEKNNS HHHHHCCCCCHHCCC | 16.46 | 28152594 | |
| 78 | Acetylation | AAGYDVEKNNSRIKL HCCCCCHHCCCCEEE | 62.37 | 158567 | |
| 78 | Ubiquitination | AAGYDVEKNNSRIKL HCCCCCHHCCCCEEE | 62.37 | 21906983 | |
| 81 | Phosphorylation | YDVEKNNSRIKLGIK CCCHHCCCCEEEEHH | 44.79 | 23401153 | |
| 84 | Ubiquitination | EKNNSRIKLGIKSLV HHCCCCEEEEHHHHH | 39.28 | 23000965 | |
| 88 | Other | SRIKLGIKSLVSKGT CCEEEEHHHHHHCCC | 35.62 | - | |
| 88 | Ubiquitination | SRIKLGIKSLVSKGT CCEEEEHHHHHHCCC | 35.62 | 23000965 | |
| 88 | Acetylation | SRIKLGIKSLVSKGT CCEEEEHHHHHHCCC | 35.62 | 19608861 | |
| 89 | Phosphorylation | RIKLGIKSLVSKGTL CEEEEHHHHHHCCCE | 31.89 | 20860994 | |
| 92 | Phosphorylation | LGIKSLVSKGTLVQT EEHHHHHHCCCEEEE | 30.57 | 20860994 | |
| 93 | Ubiquitination | GIKSLVSKGTLVQTK EHHHHHHCCCEEEEC | 48.73 | 23000965 | |
| 93 | Acetylation | GIKSLVSKGTLVQTK EHHHHHHCCCEEEEC | 48.73 | 19608861 | |
| 93 | Malonylation | GIKSLVSKGTLVQTK EHHHHHHCCCEEEEC | 48.73 | 26320211 | |
| 93 | Other | GIKSLVSKGTLVQTK EHHHHHHCCCEEEEC | 48.73 | - | |
| 95 | Phosphorylation | KSLVSKGTLVQTKGT HHHHHCCCEEEECCC | 27.74 | 29514088 | |
| 99 | Phosphorylation | SKGTLVQTKGTGASG HCCCEEEECCCCCCC | 24.78 | 28111955 | |
| 100 | Ubiquitination | KGTLVQTKGTGASGS CCCEEEECCCCCCCC | 37.07 | 23000965 | |
| 100 | Acetylation | KGTLVQTKGTGASGS CCCEEEECCCCCCCC | 37.07 | - | |
| 102 | Phosphorylation | TLVQTKGTGASGSFK CEEEECCCCCCCCEE | 31.00 | 26657352 | |
| 105 | Phosphorylation | QTKGTGASGSFKLNK EECCCCCCCCEEECC | 35.99 | 25159151 | |
| 107 | Phosphorylation | KGTGASGSFKLNKKA CCCCCCCCEEECCCC | 19.40 | 23401153 | |
| 109 | Acetylation | TGASGSFKLNKKASS CCCCCCEEECCCCCC | 53.50 | 22648197 | |
| 109 | Ubiquitination | TGASGSFKLNKKASS CCCCCCEEECCCCCC | 53.50 | 21963094 | |
| 109 | Other | TGASGSFKLNKKASS CCCCCCEEECCCCCC | 53.50 | - | |
| 112 | Ubiquitination | SGSFKLNKKASSVET CCCEEECCCCCCCCC | 61.22 | 22817900 | |
| 113 | Ubiquitination | GSFKLNKKASSVETK CCEEECCCCCCCCCC | 53.05 | 22817900 | |
| 115 | Phosphorylation | FKLNKKASSVETKPG EEECCCCCCCCCCCC | 43.74 | 30622161 | |
| 116 | Phosphorylation | KLNKKASSVETKPGA EECCCCCCCCCCCCC | 28.91 | 30622161 | |
| 119 | Phosphorylation | KKASSVETKPGASKV CCCCCCCCCCCCCHH | 40.14 | 30622161 | |
| 120 | Ubiquitination | KASSVETKPGASKVA CCCCCCCCCCCCHHC | 28.13 | 23000965 | |
| 124 | Phosphorylation | VETKPGASKVATKTK CCCCCCCCHHCHHHC | 33.31 | 29083192 | |
| 125 | Acetylation | ETKPGASKVATKTKA CCCCCCCHHCHHHCC | 35.04 | - | |
| 125 | Lactylation | ETKPGASKVATKTKA CCCCCCCHHCHHHCC | 35.04 | 31645732 | |
| 125 | Ubiquitination | ETKPGASKVATKTKA CCCCCCCHHCHHHCC | 35.04 | 23000965 | |
| 128 | Phosphorylation | PGASKVATKTKATGA CCCCHHCHHHCCCCC | 42.08 | 29083192 | |
| 129 | Lactylation | GASKVATKTKATGAS CCCHHCHHHCCCCCH | 37.99 | 31645732 | |
| 129 | Ubiquitination | GASKVATKTKATGAS CCCHHCHHHCCCCCH | 37.99 | 23000965 | |
| 131 | Ubiquitination | SKVATKTKATGASKK CHHCHHHCCCCCHHH | 45.57 | 23000965 | |
| 133 | Phosphorylation | VATKTKATGASKKLK HCHHHCCCCCHHHHH | 34.53 | 29396449 | |
| 143 | Phosphorylation | SKKLKKATGASKKSV HHHHHHHHCCCHHCC | 42.01 | 29759185 | |
| 146 | Phosphorylation | LKKATGASKKSVKTP HHHHHCCCHHCCCCC | 41.80 | 29759185 | |
| 149 | Phosphorylation | ATGASKKSVKTPKKA HHCCCHHCCCCCHHH | 32.36 | 29759185 | |
| 152 | Phosphorylation | ASKKSVKTPKKAKKP CCHHCCCCCHHHCCC | 37.88 | 20551309 | |
| 162 | Phosphorylation | KAKKPAATRKSSKNP HHCCCCCCCCCCCCC | 40.51 | 22817900 | |
| 165 | Phosphorylation | KPAATRKSSKNPKKP CCCCCCCCCCCCCCC | 43.16 | 20068231 | |
| 166 | Phosphorylation | PAATRKSSKNPKKPK CCCCCCCCCCCCCCC | 39.21 | 20068231 | |
| 174 | Phosphorylation | KNPKKPKTVKPKKVA CCCCCCCCCCCCHHC | 42.14 | 26657352 | |
| 183 | Phosphorylation | KPKKVAKSPAKAKAV CCCHHCCCHHHHHCC | 21.98 | 20551309 | |
| 204 | Phosphorylation | ARVTKPKTAKPKKAA CCCCCCCCCCCCCCC | 48.73 | 22817900 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 57 | R | Citrullination |
| - |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of H11_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-88, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-162, AND MASSSPECTROMETRY. | |